Eli Lilly and Co.’s approval for Omvoh to treat moderate to severe Crohn’s disease in adults marks the Indianapolis company’s growing presence in the treatment of inflammatory bowel disease.
Hosted on MSN15d
Butler intends to honor Clowes' history during expansionINDIANAPOLIS (Mirror Indy) — When Clowes Memorial Hall opened on Butler University's campus in October 1963 ... best known for introducing mass insulin production at Eli Lilly and Co. Woollen was 32 ...
INDIANAPOLIS (Mirror Indy) — When Clowes Memorial Hall opened on Butler University’s campus in October 1963 ... mass insulin production at Eli Lilly and Co. Woollen was 32 when he was chosen ...
Sales of Lilly’s top-selling product, the diabetes treatment Mounjaro, jumped 60% to $3.53 billion in the final quarter of ...
Analysts expect the Indianapolis, Indiana-based company to report quarterly earnings at $5.08 per share, up from $2.49 per ...
Lilly's fourth-quarter earnings, released before the market opened Thursday, surpassed analysts' expectations by millions.
Eli Lilly and Co. (LLY) on Thursday reported fourth-quarter earnings of $4.41 billion. The Indianapolis-based company said it had profit of $4.88 per share.
Eli Lilly has named Winselow Tucker as President and General Manager for India. Tucker will oversee operations, including the Lilly India commercial organization and the Lilly Capability Centre India.
SAN FRANCISCO — Eli Lilly said Monday it would acquire a cancer program from startup Scorpion Therapeutics in a deal worth up to $2.5 billion, as the Indianapolis company broadens its pipeline.
Eli Lilly LLY-0.39%decrease ... sees healthy growth in 2025 due to the success of its weight-loss drugs. The Indianapolis-based pharmaceutical company said it expects fourth-quarter revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results